Evidence for interleukin-10-mediated inhibition of cyclo-oxygenase-2 expression and prostaglandin production in preterm human placenta

American Journal of Reproductive Immunology

Volumn 55, Issue 1, 2006, Pages 19-27

  Hanna, Nazeeh ^a   Bonifacio, Lea ^a   Weinberger, Barry ^a   Reddy, Pradeep ^a   Murphy, Shaun ^b   Romero, Roberto ^c,d   Sharma, Surendra ^b,e  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Cyclo oxygenase 2; Inflammation; Interleukin 10; Placental explants; Preterm labor

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROSTAGLANDIN; PROSTAGLANDIN E2;

ADULT; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; GESTATION PERIOD; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLACENTA; PREMATURE LABOR; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECOND TRIMESTER PREGNANCY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ADOLESCENT; ADULT; CHORIOAMNIONITIS; CYCLOOXYGENASE 2; FEMALE; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; OBSTETRIC LABOR, PREMATURE; PLACENTA; PREGNANCY; PROSTAGLANDINS E; TERM BIRTH; TISSUE CULTURE TECHNIQUES; TROPHOBLASTS;

EID: 33644697076     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2005.00342.x     Document Type: Article

References (44)

1. McCormick MC: The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985; 312: 82 - 90.
2. Hack M, Fanaroff AA: Outcomes of extremely immature infants - a perinatal dilemma. N Engl J Med 1993; 329: 1649 - 1650.
3. Nathanielsz PW: The role of basic science in preventing low birth weight. Future Child 1995; 5: 57 - 70.
4. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL: A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992 166: 1515 - 1528.
5. Dudley DJ:APre-term labor: an intra-uterine inflammatory response syndrome ? J Reprod Immunol 1997; 36: 93 - 109.
6. Gomes R, Romero R, Edwin SS, David C: Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intra-amniotic infection. Infect Dis Clin Am 1997; 11: 135 - 176.
7. Gomez R, Romero R, Mazor M, Ghezzi F, David C, Yoon BH: Role of infection in preterm labor and delivery. Preterm Labor, MG Elder, R Romero, RF Lamont (eds). New York, Churchill Livingstone, 1997, pp 85 - 125.
8. Goncalves LF, Chaiworapongsa T, Romero R: Intrauterine infection and prematurity. MRDD Res Rev 2002; 8: 3 - 13.
9. Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA: A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988; 319: 972 - 978.
10. Yoon BH, Romero R, Park JS, Kim M, Oh SY, Kim CJ, Jun JK: The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000; 183: 1124 - 1129.
11. Challis JR, Lye SJ, Gibb W, Whittle W, Patel F, Alfaidy N: Understanding preterm labor. Ann N Y Acad Sci 2001; 943: 225 - 234.
12. Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, Mitchell MD: Cytokines, prostaglandins and parturition - a review. Placenta 2003; 24: S33 - S46.
13. Hertelendy F, Zakar T: Regulation of myometrial smooth muscle functions. Curr Pharm Des 2004; 10: 2499 - 2517.
14. Olson DM: The role of prostaglandins in the initiation of parturition. Best Pract Res Clin Obstet Gynecol 2003; 17: 717 - 730.
15. Peltier MR: Immunology of term and preterm labor. Reprod Biol Endocrinol 2003; 1: 1 - 11.
16. Meis PJ, Connors N: Progesterone treatment to prevent preterm birth. Clin Obstet Gynecol 2004; 47: 784 - 795.
17. Brown NL, Alvi SA, Elder MG, Bennett PR, Sullivan MH: The regulation of prostaglandin output from term intact fetal membranes by anti-inflammatory cytokines. Immunology 2000; 99: 124 - 133.
18. Romero R, Baumann P, Gomez R, Salafia C, Rittenhouse L, Barberio D Behnke E, Cotton DB, Mitchell MD: The relationship between spontaneous rupture of membranes, labor, and microbial invasion of the amniotic cavity and amniotic fluid concentrations of prostaglandins and thromboxane B2 in term pregnancy. Am J Obstet Gynecol 1993; 168: 1654 - 1664.
19. Challis JR, Patel FA, Pomini F: Prostaglandin dehydrogenase and the initiation of labor. J Perinatal Med 1999; 27: 26 - 34.
20. Hanna N, Hanna I, Wagner E, Hleb M, Balkundi D, Sharma S: Gestational age dependent expression of interleukin-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol 2000; 164: 5721 - 5728.
21. Terrone DA, Rinehart BK, Granger JP, Barrilleaux PS, Martin JN, Jr Bennett W: Intereleukin-10 administration and bacterial endotoxin-induced preterm birth in a rat model. Obstet Gynecol 2001; 98: 476 - 480.
22. Sadosky DW, Novy MJ, Witkin SS, Gravett MG: Dexamethasone or interleukin-10 blocks interleukin-1 β -induced uterine contractions in pregnant rhesus monkeys. Am J Obstet Gynecol 2003; 188: 252 - 263.
23. Smith WL, Garavito M, DeWitt DL: Prostaglandin endoperoxide H synthases (cyclooxygenases) -1 and -2. J Biol Chem 1996; 271: 33157 - 33160.
24. Plevyak M, Hanna N, Mayer S, Murphy S, Pinar H, Fast L, Ekerfelt C Ernerudh J, Berg G, Matthiesen L, Sharma S: Deficiency of decidual IL-10 in first trimester missed abortion: A lack of correlation with the decidual immune cell profile. Am J Reprod Immunol 2002; 47: 242 - 250
25. Blanco JCG, Contursi C, Salkowski CA, DeWitt DL, Ozato K, Vogel SN: Interferon regulatory factors (IRF)-1 and IRF-2 regulate interferon γ -dependent cyclooxygenase 2 expression. J Exp Med 2000; 191: 2131 - 2144.
26. Hanna N, Bonifacio P, Reddy P, Hanna I, Weinberger B, Murphy S, Laskin D, Sharma S: IFN- γ -mediated inhibition of COX-2 expression in the placenta from term and preterm labor pregnancies. Am J Reprod Immunol 2004; 51: 311 - 318.
27. Rice GE, Wohg MH, Thorburu GD: Gestational changes in prostaglandin synthase activity of ovine cotyledonary microsomes. J Endocrinol 1988; 118: 265 - 270.
28. Steinborn A, Gunes H, Halberstadt E: Signal for term parturition is of trophoblast and therefore of fetal origin. Prostaglandins 1995; 50: 237 - 252.
29. Challis JR, Sloboda DM, Alfaidy N, Lye SJ, Gibb W, Patel FA, Whittle WL, Newnham JP: Prostaglandins and mechanisms of preterm birth. Reproduction 2002; 124: 1 - 17.
30. Kniss DA: Cyclooxygenases in reproductive medicine and biology. J Soc Gynecol Investig 1999; 6: 285 - 292.
31. Taniquchi T, Matsuzaki N, Kameda T, Shimoya K, Jo T, Saji F, Tanizawa O: The enhanced production of placental interleukin-1 during labor and intrauterine infection. Am J Obstet Gynecol 1991; 165: 131 - 137.
32. Yan X, Wu Xiao C, Sun M, Tsang BK, Gibb W: Nuclear factor kappa B activation and regulation of cyclooxygenase type-2 expression in human amnion mesenchymal cells by interleukin-1beta. Biol Reprod 2002; 66: 1667 - 1671.
33. Pomini F, Caruso A, Challis JR: Interleukin-10 modifies the effects of interleukin 1beta and tumor necrosis factor-alpha on the activity and expression of prostaglandin H synthase-2 and the NAD+ dependent 15-hydroxyprostaglandin dehydrogenase in cultured term human villous trophoblast and chorion trophoblast cells. J Clin Endocrinol Metab 1999; 84: 4645 - 4651.
34. Rosenstock M, Danon A, Rimon G: PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity. Biochim Biophys Acta 1999; 1440: 127 - 137.
35. Everts B, Wahrborg P, Hedner T: COX-2-specific inhibitors - the emergence of a new class of analgesic and anti-inflammatory drugs. Clin Rheumatol 2000; 19: 331 - 343.
36. Loudon JA, Groom KM, Bennett PR: Prostaglandin inhibitors in preterm labour. Best Pract Res Clin Obstet Gynaecol 2003; 17: 731 - 744.
37. Burdan F, Dudka J, Szumilo J, Korobowicz A, Klepacz L: Prenatal effects of DuP-697 - the irreversible, highly selective cyclooxygenase-2 inhibitor. Reprod Toxicol 2003; 17: 413 - 419.
38. Otto JC, Smith WL: Prostaglandin endoperoxide synthase-1 and -2. J Lipid Mediat Cell Signal 1995; 12: 139 - 156.
39. Barrios-Rodiles M, Chadee K: Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-gamma in human macrophages. J Immunol 1998; 161: 2441 - 2448.
40. Hertelendy F, Molnar M, Romero R: Interferon gamma antagonizes interleukin-1beta-induced cyclooxygenase-2 expression and prostaglandin E(2) production in human myometrial cells. J Soc Gynecol Investig 2002; 9: 215 - 219.
41. Pacora P, Romero R, Maymon E, Gervasi MT, Gomez R, Edwin SS, Yoon BH: Participation of the novel cytokine interleukin 18 in the host response to intra-amniotic infection. Am J Obstet Gynecol 2000; 183: 1138 - 1143.
42. Maymon E, Romero R, Pacora P, Gervasi MT, Gomez R, Edwin SS, Yoon BH: Evidence of in vivo differential bioavailabilty of the active forms of matrix metalloprotienases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection. Am J Obstet Gynecol 2000; 183: 887 - 894.
43. Murphy S, Fast L, Hanna N, Sharma S: Uterine NK cells mediate inflammation-induced fetal demise in IL-10-null mice. J Immunol 2005; 175: 4084 - 4090.
44. Berg DJ, Zhang J, Lauricella DM, Moore SA: IL-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production. J Immunol 2001; 166: 2674 - 2680.